主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1402
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.48%
每月变动
+10.77%
6个月变化
+1.35%
年变化
+1.35%
前一天收盘价
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
交易量
97
市场
股票
医疗保健
SUPN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
TD Cowen上调Supernus Pharmaceuticals目标价,看好Onapgo重新上市
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Supernus Pharmaceuticals股价触及52周高点57.76美元
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald维持Supernus股票增持评级,看好供应增长
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Supernus Pharmaceuticals Q4 每股收益 逊于预期, 营收 超出预期
Supernus earnings missed by $0.48, revenue topped estimates
Supernus财报考验:第三季度盈利能力受挫后迎来关键测试
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline